Loading market dashboard
Unity Biotechnology, Inc.
UBXHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Unity Biotechnology, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $15.76M | $15.76M - $15.76M | $3.15M | $0.13 | 2 |
| Dec 2028 | $8.57M | $8.57M - $8.57M | $1.71M | -$0.055 | 1 |
| Dec 2027 | $19.86M | $19.86M - $19.86M | $3.97M | -$0.571 | 3 |
| Dec 2026 | $6.19M | $6.19M - $6.19M | $1.24M | -$0.82 | 4 |
| Dec 2025 | $500.0K | $500.0K - $500.0K | $100.0K | -$1.076 | 2 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.371 | 0 |
| Dec 2023 | $0.00 | $0.00 - $0.00 | $0.00 | -$2.832 | 0 |
| Dec 2022 | $218.0K | $218.0K - $218.0K | $43.6K | -$4.034 | 1 |